“The present circumstance has exposed some structural weaknesses in the EU’s medicines provide chain along with a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain problems be dealt with within an EU pharmaceutical technique expected to become rele… Read More